{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:36:35Z","timestamp":1791279395356,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jns.2007.05.024","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T07:27:05Z","timestamp":1185866825000},"page":"3-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The role of optical coherence tomography in multiple sclerosis: Expert panel consensus"],"prefix":"10.1016","volume":"263","author":[{"given":"Robert C.","family":"Sergott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Frohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Glanzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"AL-Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2007.05.024_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.410380610","article-title":"Chemical pathology of acute demyelinating lesions and its correlation with disability","volume":"38","author":"De Stefano","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.05.024_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.icu.0000188705.67815.0e","article-title":"Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis","volume":"16","author":"Sergott","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/86589","article-title":"Ultrahigh-resolution ophthalmic optical coherence tomography","volume":"7","author":"Drexler","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2007.05.024_bib4","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.53.3.473","article-title":"Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey","volume":"53","author":"Sorensen","year":"1999","journal-title":"Neurology"},{"issue":"suppl","key":"10.1016\/j.jns.2007.05.024_bib6","first-page":"96","article-title":"Optic neuritis","volume":"99","author":"Cantore","year":"1996","journal-title":"Pa Med"},{"key":"10.1016\/j.jns.2007.05.024_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.05.024_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuroimage.2005.09.024","article-title":"Optic nerve diffusion tensor imaging in optic neuritis","volume":"30","author":"Trip","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.jns.2007.05.024_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jns.2007.05.024_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1983.tb04846.x","article-title":"The incidence of optic neuritis and its prognosis for multiple sclerosis","volume":"68","author":"Kinnunen","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2007.05.024_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic neuritis: a population-based study in Olmsted County, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology"},{"issue":"Pt 4","key":"10.1016\/j.jns.2007.05.024_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jns.2007.05.024_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1076\/ocii.10.3.161.15603","article-title":"Optic neuritis in multiple sclerosis","volume":"10","author":"Chan","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jns.2007.05.024_bib14","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","article-title":"Management of acute optic neuritis","volume":"360","author":"Hickman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2007.05.024_bib15","series-title":"Walsh and Hoyt's Clinical Neuro-Ophthalmology","first-page":"599","article-title":"Optic neuritis","author":"Beck","year":"1998"},{"key":"10.1016\/j.jns.2007.05.024_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.55.9.747","article-title":"The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system","volume":"55","author":"McDonald","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2007.05.024_bib17","first-page":"180","article-title":"Neuro-ophthalmology of multiple sclerosis","volume":"2","author":"Warner","year":"1994","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.jns.2007.05.024_bib18","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10\u00a0years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.10148","article-title":"Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses","volume":"51","author":"Beck","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.05.024_bib20","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2007.05.024_bib21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2007.05.024_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archopht.1995.01100050054031","article-title":"Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography","volume":"113","author":"Schuman","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archopht.118.1.22","article-title":"The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography","volume":"118","author":"Bowd","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroimage.2005.11.051","article-title":"Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy","volume":"31","author":"Trip","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.jns.2007.05.024_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2007.05.024_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002340000450","article-title":"Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence","volume":"43","author":"Hickman","year":"2001","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jns.2007.05.024_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1191\/1352458502ms809oa","article-title":"Continuing optic nerve atrophy following optic neuritis: a serial MRI study","volume":"8","author":"Hickman","year":"2002","journal-title":"Mult Scler"},{"issue":"Pt 8","key":"10.1016\/j.jns.2007.05.024_bib28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/brain\/121.8.1469","article-title":"Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study","volume":"121","author":"De Stefano","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jns.2007.05.024_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410410314","article-title":"Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions","volume":"41","author":"Narayanan","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.05.024_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archopht.1974.01010010097001","article-title":"Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints","volume":"92","author":"Frisen","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib31","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/jnnp.38.11.1109","article-title":"Subclinical optic neuropathy in multiple sclerosis. How early VER components reflect axon loss and conduction defects in optic pathways","volume":"38","author":"Feinsod","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.jns.2007.05.024_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awg038","article-title":"Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis","volume":"126","author":"Filippi","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2007.05.024_bib33","series-title":"Poster presented at: European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting; September 28\u2013October 1, 2005","article-title":"In vivo neuroprotection with high-dose, high-frequency interferon therapy: a serial optical coherence tomography study in multiple sclerosis and optic neuritis","author":"Sergott","year":"2005"},{"key":"10.1016\/j.jns.2007.05.024_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/01.WNL.0000094315.19931.90","article-title":"Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite","volume":"61","author":"Balcer","year":"2003","journal-title":"Neurology"},{"issue":"Pt 9","key":"10.1016\/j.jns.2007.05.024_bib35","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","article-title":"Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis","volume":"124","author":"Evangelou","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2007.05.024_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0896-1549(03)00102-0","article-title":"Imaging in glaucoma","volume":"17","author":"Stein","year":"2004","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.jns.2007.05.024_bib37","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/S0161-6420(00)00341-9","article-title":"Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography","volume":"107","author":"Blumenthal","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jns.2007.05.024_bib38","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1167\/iovs.03-0514","article-title":"Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT","volume":"45","author":"Paunescu","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jns.2007.05.024_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00061198-199908000-00004","article-title":"Increasing sampling density improves reproducibility of optical coherence tomography measurements","volume":"8","author":"Gurses-Ozden","year":"1999","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jns.2007.05.024_bib40","series-title":"StratusOCT\u2122: establishment of normative reference values for retinal nerve fiber thickness measurements","author":"Patella","year":"2003"},{"key":"10.1016\/j.jns.2007.05.024_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archopht.121.1.41","article-title":"Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography","volume":"121","author":"Greenfield","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jns.2007.05.024_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-6420(02)01564-6","article-title":"Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes","volume":"110","author":"Guedes","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jns.2007.05.024_bib43","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients","volume":"40","author":"Parisi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jns.2007.05.024_bib44","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.05.024_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jns.2006.08.012","article-title":"Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis","volume":"250","author":"Pro","year":"2006","journal-title":"J Neurol Sci"},{"issue":"suppl 24","key":"10.1016\/j.jns.2007.05.024_bib46","first-page":"1","article-title":"Neurological disease in an English city","volume":"42","author":"Rewis","year":"1966","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2007.05.024_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410160302","article-title":"Neuroepidemiology","volume":"16","author":"Kurtzke","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.05.024_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000110900","article-title":"Incidence of multiple sclerosis in Denmark 1948\u20131982: a descriptive nationwide study","volume":"11","author":"Koch-Henriksen","year":"1992","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2007.05.024_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.43.4.310","article-title":"A further prevalence study of multiple sclerosis in north-east Scotland","volume":"43","author":"Shepherd","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2007.05.024_bib50","series-title":"Neurological Rehabilitation","first-page":"3","article-title":"The epidemiology of disabling neurological disorders","author":"Langton Hewer","year":"1993"},{"key":"10.1016\/j.jns.2007.05.024_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jnnp.58.1.27","article-title":"A prevalence survey of multiple sclerosis in Sussex","volume":"58","author":"Rice-Oxley","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2007.05.024_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.50.2.423","article-title":"An epidemiologic study of multiple sclerosis in Northern Ireland","volume":"50","author":"McDonnell","year":"1998","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07003838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07003838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:39:39Z","timestamp":1758382779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X07003838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0022510X07003838"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2007.05.024","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of optical coherence tomography in multiple sclerosis: Expert panel consensus","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2007.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}